The Lancet The Lancet, Elsevier, 2019, 394 (10204), pp.1169-1180. ⟨10.1016/S0140-6736(19)31887-2⟩ The Lancet (London), 394, 1169-1180 Bhatt, D L, Steg, P G, Mehta, S R, Leiter, L A, Simon, T, Fox, K, Held, C, Andersson, M, Himmelmann, A, Ridderstråle, W, Chen, J, Song, Y, Diaz, R, Goto, S, James, S K, Ray, K K, Parkhomenko, A N, Kosiborod, M N, McGuire, D K, Harrington, R A & THEMIS Steering Committee and Investigators 2019, ' Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI) : a phase 3, placebo-controlled, randomised trial ', Lancet, vol. 394, no. 10204, pp. 1169-1180 . https://doi.org/10.1016/S0140-6736(19)31887-2 The Lancet (London), 394, 10204, pp. 1169-1180
Holman, R R, Bethel, M A, Mentz, R J, Thompson, V P, Lokhnygina, Y, Buse, J B, Chan, J C, Choi, J, Gustavson, S M, Iqbal, N, Maggioni, A P, Marso, S P, Öhman, P, Pagidipati, N J, Poulter, N, Ramachandran, A, Zinman, B, Hernandez, A F, EXSCEL Study Group & Serné, EH 2017, ' Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes ', New England Journal of Medicine, vol. 377, no. 13, pp. 1228-1239 . https://doi.org/10.1056/NEJMoa1612917 New England Journal of Medicine, 377(13), 1228-1239. Massachussetts Medical Society N Engl J Med
New England Journal of Medicine New England Journal of Medicine, Massachusetts Medical Society, 2013, 369 (22), pp.2093-104. ⟨10.1056/NEJMoa1310907⟩ New England journal of medicine, 369(22), 2093-2104. Massachussetts Medical Society The New England Journal of Medicine, 369, 2093-104 The New England Journal of Medicine, 369, 22, pp. 2093-104
Repositorio Abierto de la UdL Universitad de Lleida Dipòsit Digital de la UB Universidad de Barcelona Recercat. Dipósit de la Recerca de Catalunya instname
NEW ENGLAND JOURNAL OF MEDICINE r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau instname